BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hall V, Johnson D, Torresi J. Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations. J Travel Med 2018;25. [PMID: 29635641 DOI: 10.1093/jtm/tay018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Morel J, Tournadre A, Sellam J, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C. Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105221. [PMID: 34183155 DOI: 10.1016/j.jbspin.2021.105221] [Reference Citation Analysis]
2 Allen V, Longley N. Infections in Immunosuppressed Travellers with Autoimmune Inflammatory Diseases-A Narrative Review and Advice for Clinical Practice. Rheumatology (Oxford) 2021:keab445. [PMID: 34022043 DOI: 10.1093/rheumatology/keab445] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Freedman DO, Chen LH. Vaccines for International Travel. Mayo Clin Proc 2019;94:2314-39. [PMID: 31685156 DOI: 10.1016/j.mayocp.2019.02.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Yates JA, Rao SR, Walker AT, Esposito DH, Sotir M, LaRocque RC, Ryan ET; Global TravEpiNet Consortium. Characteristics and preparation of the last-minute traveler: analysis of vaccine usage in the Global TravEpiNet Consortium. J Travel Med 2019;26:taz031. [PMID: 31044254 DOI: 10.1093/jtm/taz031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Kling K, Wichmann O, Burchard G. [Travel vaccinations for certain groups of persons]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020;63:85-92. [PMID: 31811312 DOI: 10.1007/s00103-019-03067-w] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Hosseini-Shokouh SJ, Sheikhi RA, Hosseini SMR, Moradimajd P. The biological weapons threats and coping strategies for health promotion. J Educ Health Promot 2021;10:127. [PMID: 34222502 DOI: 10.4103/jehp.jehp_717_20] [Reference Citation Analysis]
7 Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-ladner U, Niehues T, Überla K, Vygen-bonnet S, Weinke T, Wiese-posselt M, Wojcinski M, Zepp F. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie. Bundesgesundheitsbl 2019;62:494-515. [DOI: 10.1007/s00103-019-02905-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 27] [Article Influence: 20.0] [Reference Citation Analysis]
8 Torresi J, Mcguinness S, Leder K, O’brien D, Ruff T, Starr M, Gibney K. Travellers with Special Needs. Manual of Travel Medicine. Singapore: Springer; 2019. pp. 297-376. [DOI: 10.1007/978-981-13-7252-0_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Makhani L, Khatib A, Corbeil A, Kariyawasam R, Raheel H, Clarke S, Challa P, Hagopian E, Chakrabarti S, Schwartz KL, Boggild AK. 2018 in review: five hot topics in tropical medicine. Trop Dis Travel Med Vaccines 2019;5:5. [PMID: 31016025 DOI: 10.1186/s40794-019-0082-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
10 Lutz J, Rieke A, Rieke B. [Traveling with immunodeficiency-Problems and prevention]. Internist (Berl) 2019;60:701-8. [PMID: 31098645 DOI: 10.1007/s00108-019-0617-4] [Reference Citation Analysis]
11 Freudenhammer M, Hufnagel M. [Travelling with children and adolescents with rheumatic diseases]. Z Rheumatol 2021;80:620-8. [PMID: 33904986 DOI: 10.1007/s00393-021-01002-6] [Reference Citation Analysis]
12 Tournadre A, Sellam J, Morel J, Jullien D, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Goupille P, Kluger N, Lazaro E, Goff BL, Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Richez C, Pham T. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105210. [PMID: 34074455 DOI: 10.1016/j.jbspin.2021.105210] [Reference Citation Analysis]
13 Koehl B, Aupiais C, Schinckel N, Mornand P, Odièvre MH, Niakate A, Brousse V, Ithier G, Missud F, Holvoet L, Benkerrou M, Sorge F, Faye A. Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study. J Travel Med 2021;28:taab013. [PMID: 33550421 DOI: 10.1093/jtm/taab013] [Reference Citation Analysis]
14 Prentice RE, Rentsch C, Al-Ani AH, Zhang E, Johnson D, Halliday J, Bryant R, Begun J, Ward MG, Lewindon PJ, Connor SJ, Ghaly S, Christensen B. SARS-CoV-2 vaccination in patients with inflammatory bowel disease. GastroHep 2021;3:212-28. [PMID: 34539248 DOI: 10.1002/ygh2.473] [Reference Citation Analysis]
15 Szabados F, Kragh J, Rasmussen C, Leutscher PDC. Biological therapy and international travel: A questionnaire survey among Danish patients with rheumatic disease. Eur J Rheumatol 2020. [PMID: 32910755 DOI: 10.5152/eurjrheum.2020.19190] [Reference Citation Analysis]
16 von Asmuth EGJ, Brockhoff HJ, Wallinga J, Visser LG. S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease. J Travel Med 2019;26. [PMID: 30137469 DOI: 10.1093/jtm/tay073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ashkenazi S, Schwartz E. Traveler's diarrhea in children: New insights and existing gaps. Travel Med Infect Dis 2020;34:101503. [PMID: 31654742 DOI: 10.1016/j.tmaid.2019.101503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mateo L, Pedro-Botet ML, Esteve MG, Carrascosa JM; en representación del Comité de infecciones en paciente tratados con inmunosupresores selectivos del Hospital Germans Trias i Pujol. Contributions from a multidisciplinary committee for the prevention of infections in patients with targeted immunosuppressive therapy. Med Clin (Barc) 2021:S0025-7753(21)00244-X. [PMID: 34103165 DOI: 10.1016/j.medcli.2021.03.031] [Reference Citation Analysis]